Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Brecht, Isabel ^a   Weissbrich, Benedikt ^a   Braun, Julia ^a   Toyka, Klaus Viktor ^a   Weishaupt, Andreas ^a   Buttmann, Mathias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; CHICKENPOX; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; GERMAN; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; MALE; MEASLES; MULTIPLE SCLEROSIS; OLIGOCLONAL BAND NEGATIVE MULTIPLE SCLEROSIS; RUBELLA; VIRUS DETECTION; WESTERN HEMISPHERE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, HUMORAL; MALE; MEASLES VIRUS; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; OLIGOCLONAL BANDS; RUBELLA VIRUS; YOUNG ADULT;

RUBELLA; SIMPLEXVIRUS;

EID: 84863615313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040431     Document Type: Article

References (16)

1. Reiber H, Ungefehr S, Jacobi C, (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4: 111-117.
2. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
3. Reiber H, Lange P, (1991) Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 37: 1153-1160.
4. Bednarova J, Stourac P, Adam P, (2005) Relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol Scand 112: 97-102.
5. Jarius S, Eichhorn P, Jacobi C, Wildemann B, Wick M, et al. (2009) The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity? J Neurol Sci 280: 98-100.
6. Jarius S, Franciotta D, Bergamaschi R, Rauer S, Wandinger KP, et al. (2008) Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 79: 1134-1136.
7. Sindic CJ, Monteyne P, Laterre EC, (1994) The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 54: 75-80.
8. Felgenhauer K, Reiber H, (1992) The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Investig 70: 28-37.
9. Puccioni-Sohler M, Kitze B, Felgenhauer K, Graef IT, Lange P, et al. (1995) The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis. Arq Neuropsiquiatr 53: 760-765.
10. Reiber H, Felgenhauer K, (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163: 319-328.
11. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58: 840-846.
12. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA, et al. (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14: 1157-1174.
13. Schubert J, Weissbrich B, (2007) Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system. BMC Neurol 7: 12.
14. Thompson A, (2004) Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler 10: S2-7.
15. Kira J, (2003) Multiple sclerosis in the Japanese population. Lancet Neurol 2: 117-127.
16. Reiber H, (1995) External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients. Clin Chem 41: 256-263.